Related Experiment Video
Updated: May 13, 2025
09:24
A Protocol to Evaluate and Quantify Retinal Pigmented Epithelium Pathologies in Mouse Models of Age-Related Macular Degeneration
Published on: March 10, 2023
1.4K
Development of a human RPE In vitro model with AMD-like features reveals blue light-induced modulation of the
Camilla Di Meo1, Annamaria Tisi2, Anna Rita Lizzi2
1Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100, L'Aquila, Italy; Department of Veterinary Medicine, University of Teramo, Teramo, Italy.
Summary
Blue light exposure damages retinal cells, a key factor in age-related macular degeneration. This study reveals that blue light disrupts the endocannabinoid system in retinal pigment epithelium cells, indicating a new pathway for AMD development.
Area of Science:
- Ophthalmology
- Cell Biology
- Neuroscience
Background:
- Blue light (BL) is a significant risk factor for age-related macular degeneration (AMD).
- Damage to the retinal pigment epithelium (RPE) is an early indicator of AMD.
- The endocannabinoid system (ECS) plays a role in retinal health, but its function in BL-injured RPE is unknown.
Purpose of the Study:
- To investigate the effects of blue light on human RPE cells.
- To determine if the endocannabinoid system is involved in blue light-induced RPE damage.
- To establish an in vitro model for studying AMD pathogenesis.
Main Methods:
- Development of an in vitro model of blue light-induced human RPE damage.
- Assessment of key AMD features including cytotoxicity, cell cycle arrest, oxidative stress, inflammation, and senescence.
- Analysis of gene and protein expression of endocannabinoid system components.
Main Results:
- The in vitro model successfully replicated key features of AMD in RPE cells.
- Blue light exposure led to cytotoxicity, cell cycle arrest, oxidative stress, inflammation, and senescence.
- Significant modulation of cannabinoid receptors 1 and 2 (CB1 and CB2) gene and protein expression was observed.
Conclusions:
- The study provides the first evidence of endocannabinoid system dysregulation in RPE cells following blue light exposure.
- This highlights a novel mechanism by which blue light may contribute to AMD pathogenesis.
- The developed in vitro model serves as a valuable tool for further AMD research.
